Tagged with Talent

Saudi Arabia Having commenced his journey with American giant Lilly in 2008, and after almost eight years working in the company’s Japan organization, mostly on digital marketing, Dimitri Livadas crossed the Pacific Ocean to work in Lilly’s home market and the largest pharma market in the world, the United States, first in…

Singapore Industry veteran Marine Queniart-Stojanovic, a self-described “global citizen with a French passport,” currently serves as Sanofi’s GM for general medicines in Thailand, Malaysia, and Singapore. With Sanofi undergoing a significant transformation in its business approach, Queniart-Stojanovic is adapting this to the market realities in her managed countries as well as…

China MSD, which has had a presence in China since 1990, recently appointed Belgian national Anna van Acker to lead its strategically important China business. van Acker takes the helm against the backdrop of change at MSD, with a new global CEO and the abandonment of the company’s COVID-19 vaccine projects.…

Saudi Arabia Ashraf Daoud, General Manager for AbbVie in Saudi Arabia, highlights how the affiliate has harnessed Allergan’s portfolio to become a top five company in the market with the objective of becoming the biopharma leader by 2022. In addition, Daoud discusses the impact that an internal Saudization strategy has had, the…

Switzerland Thomas A. Tóth von Kiskér, longstanding CEO of Tillotts Pharma AG, a specialty pharma player focused on the digestive system, has overseen a number of acquisitions and the growth of the company from 30 to 300 employees. Here, he shares his insights on why M&A may be a better strategy…

China Writing in the June edition of DIA’s Global Forum magazine, Harbour BioMed’s Fang Zhou, in conversation with Sanofi China’s Irene Deng, looks at how Chinese pharmaceutical regulations have evolved and what impact this has had on regulatory professionals in the country.   The Chinese pharmaceutical industry, through the first five…

Saudi Arabia Lilly Saudi Arabia’s Dimitri Livadas shares some of the misconceptions he had before moving to the Kingdom a couple of years ago, highlights the evolution of the Saudi healthcare system with its current focus on digital health, the big opportunities for the Indiana-based company’s diabetes portfolio at a moment when…

Saudi Arabia 33-year pharma industry veteran Georg Schroeckenfuchs currently heads up the vast Middle East & Africa (MEA) region for Swiss behemoth Novartis, overseeing 19 countries, over 1800 employees, and more than USD 900 million in revenues. In a recent conversation within the frame of PharmaBoardroom’s current focus on Saudi Arabia, the…

Saudi Arabia Amgen’s Middle East and Africa General Manager Mohamed Nasser discusses the company’s approach to the region; the opportunities in the Saudi market, given its improved regulatory environment; and the disadvantages of its reference pricing system. In addition, Nasser explains Amgen’s approach to Saudization and the company’s place within Saudi Arabia’s…

Saudi Arabia Historically dependent on oil, Saudi Arabia, like most countries in the Arabian Peninsula, is now investing a large chunk of the sizeable resources obtained from fossil fuels in diversifying its economy. Pharmaceuticals, as one of the strategic sectors in the country’s diversification strategy, has reaped the benefits and the Saudi…

MEA Mohamed Nasser, Amgen’s general manager for the vast Middle East & Africa (MEA) region, leverages his considerable experience managing teams across the region to highlight four skills (and one secret ingredient) that pharma country and regional managers in MEA need to succeed.   The Middle East-Africa area (MEA) is one…

Singapore Singapore – despite its modest USD 1.22 billion domestic market – has long been one of Asia’s leading biopharmaceutical hubs and a magnet for top talent. Multitudes of biopharma and medtech multinationals, as well as domestic start-ups, have based regional functions in the clean, English speaking, and well-developed city-state with…